234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy episode artwork

EPISODE · Nov 10, 2022 · 32 MIN

234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy

from The Readout Loud · host STAT

STAT Washington correspondent Sarah Owermohle joins us to explain how this week's midterm elections will affect health and medicine, and what the politicization of the pandemic means for the future of science in the U.S. We also discuss the incoming CEOs of Biogen and Seagen, plus a pair of biotech collapses.

Episode metadata supplied by the publisher feed · Published Nov 10, 2022

Embed this episode

NOW PLAYING

234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy

0:00 32:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 32 minutes long.

When was this The Readout Loud episode published?

This episode was published on November 10, 2022.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!